Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01212068 · ClinicalTrials.gov registry record

Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy

A clinical trial, sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD).

Terminated
Registry status
24
Enrollment target

NCT01212068 is a clinical trial that was terminated before completion, run by National Institute on Deafness and Other Communication Disorders (NIDCD). The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01212068 was terminated before completion, sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD).

TERMINATED
Registry status
24 participants
Enrollment target

Study Summary

Background: * People with epilepsy often have auditory processing disorders that affect their ability to hear clearly and may cause problems with understanding speech and other kinds of verbal communication. Researchers are interested in developing better ways of studying what parts of the brain are affected by hearing disorders and epilepsy, and they need better clinical tests to measure how individuals process sound. These tests will allow researchers to examine and evaluate the effects of epilepsy and related disorders on speech and communication. * A procedure called a magnetoencephalography (MEG) can be used to measure the electrical currents involved in brain activity. Researchers are interested in learning whether MEG can be used to detect differences in the processing of simple sounds in patients with epilepsy, both with and without hearing impairments. Objectives: \- To measure brain activity in hearing impaired persons with epilepsy and compare the results with those from people with normal hearing and epilepsy as well as people with normal hearing and no epilepsy. This research is performed in collaboration with Johns Hopkins Hospital and epilepsy patients must be candidates for surgery at Johns Hopkins. Eligibility: * Individuals between 18 to 55 years of age who (1) have epilepsy and have hearing impairments, (2) have epilepsy but do not have hearing impairments, or (3) are healthy volunteers who have neither epilepsy nor hearing impairments. * Participants with epilepsy must have developed seizures after 10 years of age, and must be candidates for grid implantation surgery at Johns Hopkins Hospital.. Design: * This study will require one visit of approximately 4 to 6 hours. * Participants will be screened with a full physical examination and medical history, along with a basic hearing test. * Participants will have a magnetic resonance imaging (MRI) scan of the brain, followed by a MEG scan to record magnetic field changes produced by brain acti

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2010-09-10
Est. Completion 2017-04-04

What the Registry Record Tells You About NCT01212068

The ClinicalTrials.gov registry entry for NCT01212068 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Deafness and Other Communication Disorders (NIDCD), which has 34 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01212068 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01212068 about?

NCT01212068 is a clinical study titled "Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy". Background: * People with epilepsy often have auditory processing disorders that affect their ability to hear clearly and may cause problems with understanding speech and other kinds of verbal communication. Researchers are interested in developing better ways of studying what parts of the brain ar...

What is the current status of trial NCT01212068?

This trial is currently terminated. The enrollment target is 24 participants. The study started on 2010-09-10. Estimated completion is 2017-04-04.

Who is sponsoring clinical trial NCT01212068?

This trial is sponsored by National Institute on Deafness and Other Communication Disorders (NIDCD), which has 34 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.